Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study

Aurelien Marabelle, Dung T. Le, Paolo A. Ascierto, Anna Maria Di Giacomo, Ana De Jesus-Acosta, Jean-Pierre Delord, Ravit Geva, Maya Gottfried, Nicolas Penel, Aaron R. Hansen, Sarina A. Piha-Paul, Toshihiko Doi, Bo Gao, Hyun Cheol Chung, Jose Lopez-Martin, Yung-Jue Bang, Ronnie Shapira Frommer, Manisha Shah, Razi Ghori, Andrew K. Joe, Scott K. Pruitt, Luis A. Diaz Jr

Open source

DOI: 10.1200/jco.19.02105
Published: 2020-01-01
Container: Journal of Clinical Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/jco.19.02105,
  title = {Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study},
  author = {Aurelien Marabelle and Dung T. Le and Paolo A. Ascierto and Anna Maria Di Giacomo and Ana De Jesus-Acosta and Jean-Pierre Delord and Ravit Geva and Maya Gottfried and Nicolas Penel and Aaron R. Hansen and Sarina A. Piha-Paul and Toshihiko Doi and Bo Gao and Hyun Cheol Chung and Jose Lopez-Martin and Yung-Jue Bang and Ronnie Shapira Frommer and Manisha Shah and Razi Ghori and Andrew K. Joe and Scott K. Pruitt and Luis A. Diaz Jr},
  year = {2020},
  journal = {Journal of Clinical Oncology},
  doi = {10.1200/jco.19.02105},
  url = {https://doi.org/10.1200/jco.19.02105}
}

RIS

TY  - JOUR
TI  - Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
AU  - Aurelien Marabelle
AU  - Dung T. Le
AU  - Paolo A. Ascierto
AU  - Anna Maria Di Giacomo
AU  - Ana De Jesus-Acosta
AU  - Jean-Pierre Delord
AU  - Ravit Geva
AU  - Maya Gottfried
AU  - Nicolas Penel
AU  - Aaron R. Hansen
AU  - Sarina A. Piha-Paul
AU  - Toshihiko Doi
AU  - Bo Gao
AU  - Hyun Cheol Chung
AU  - Jose Lopez-Martin
AU  - Yung-Jue Bang
AU  - Ronnie Shapira Frommer
AU  - Manisha Shah
AU  - Razi Ghori
AU  - Andrew K. Joe
AU  - Scott K. Pruitt
AU  - Luis A. Diaz Jr
PY  - 2020
JO  - Journal of Clinical Oncology
DO  - 10.1200/jco.19.02105
UR  - https://doi.org/10.1200/jco.19.02105
ER  -

APA

Marabelle, A., Le, D. T., Ascierto, P. A., Giacomo, A. M. D., Jesus-Acosta, A. D., Delord, J., Geva, R., Gottfried, M., Penel, N., Hansen, A. R., Piha-Paul, S. A., Doi, T., Gao, B., Chung, H. C., Lopez-Martin, J., Bang, Y., Frommer, R. S., Shah, M., Ghori, R., Joe, A. K., Pruitt, S. K., & Jr, L. A. D. (2020). Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study. Journal of Clinical Oncology. https://doi.org/10.1200/jco.19.02105

Source records

crossref · retrieved 2026-09-26T12:50:47.108Z